📰 Relapsed Multiple News
Relapsed Multiple News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relapsed Multiple. Real-time updates on events, politics, business and more.
June 5, 2023
Vofatamabis under clinical development by Fusion Pharmaceuticals and currently in Phase I for Relapsed Multiple Myeloma.
May 11, 2023
Advanced therapy is an ideal treatment option for multiple myeloma and may benefit patients who couldn’t get cured by other treatment options. TheHealthSite.com
June 22, 2022
*SHA acting as mute spectator, fails to respond Govind Sharma JAMMU, June 22: Several patients suffering with a specific type of blood cancer ‘Relapsed Multiple Myeloma’ are on the verge of dying as the drug they need to be given on urgent basis, are not included in the primary package code under Ayushman Bharat scheme. A number of such cancer patients or their attendants contacted Excelsior and narrated their woes as to how they have been left to die by […]